Theresa DiNardo Brown Named AVP and Executive Director of Marketing and Communications
Theresa DiNardo Brown, Chief Communications Officer of the Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, has been named Associate Vice President of Marketing and Communications for the Miller School of Medicine and UHealth, and Executive Director of Marketing and Communications for the Sylvester Comprehensive Cancer Center.
Transplant Saves Life of Baby with Rare Cancer
Makinley Edwards, who turned 1 on June 14, is like lots of adorable baby girls. Just a few months ago, however, her prospects were grim. Shortly after her birth, Makinley was diagnosed with stage 3 hepatoblastoma — a form of liver cancer that tends to strike young children. Without the life-saving liver transplant she received at the Miami Transplant Institute, she never would have reached her first birthday.
New Pediatric Center Brings Expanded Service to South Dade Families
A newly opened outpatient facility in Deering Plaza is providing South Dade families with direct, convenient access to UHealth pediatric specialists. UHealth Pediatric Specialists South, located in an office building adjacent to Jackson South Community Hospital, serves patients from newborns to age 21.
Top Urologic Researcher Wins NIH Grant to Study Potential Breakthrough Kidney Cancer Therapy
A long-time Miller School researcher, who has dedicated her career to studying the mechanisms that fuel cancers of the prostate and bladder, is now studying a promising drug combination to combat kidney cancer.
Research Describes Novel Tumor-Promoting Adaptation in Non-Small Cell Lung Carcinoma
A collaborative Miller School study led by Priyamvada Rai, Ph.D., assistant professor of medicine in the Division of Gerontology and Geriatric Medicine, describes a novel therapeutic target in RAS-driven lung cancer, a common but untreatable carcinoma. The study, published in Oncogene, describes a critical role for MTH1, a protein which sanitizes oxidized DNA precursors, in facilitating tumor formation by activated KRAS.